CRP and cancer: On univariate cancer-specific survival analysis, performance status (P<0.10), T stage (P<0.001), tumour size (P<0.10), grade (P<0.001), necrosis (P<0.01), C-reactive protein (P<0.001) and mGPS (P<0.001) were significantly associated with cancer-specific survival (Table 2).